m40403
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2001 (NCT00033956)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- imisopasem manganese
- m40403
- m40403
- m40403
- m40403
- m 40403
- m-40403
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00101621 | Phase 2 | Aug 1, 2004 | MetaPhore Pharmaceuticals |
| NCT00033956 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2001 | MetaPhore Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MetaPhore Pharmaceuticals | For profit | 2 | 2 | 1 | 2001 |
1 organizations
Page 1 / 1